| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Revenue | $593.4M | +25.8% |
| Cost of Revenue | $183.2M | +24.2% |
| Gross Profit | $410.2M | +26.5% |
| R&D Expense | $134.0M | +11.8% |
| SG&A Expense | $116.1M | +13.8% |
| Operating Income | -$122.2M | +15.6% |
| Pre-tax Income | -$100.6M | +21.7% |
| Income Tax | $3.4M | +76.0% |
| Net Income | -$103.7M |
| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $83.1M | +21.7% |
| Accounts Receivable | $95.2M | +3.2% |
| Current Assets | $644.0M | +7.1% |
| Total Assets | $871.0M | +7.4% |
| Current Liabilities | $324.5M | +12.1% |
| Total Liabilities | $396.2M | +8.1% |
| Stockholders' Equity | $474.9M | +6.9% |
| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $36.7M | +435.5% |
| Capital Expenditures | $13.2M | +35.6% |
| Investing Cash Flow | -$36.5M | -82.6% |
| Financing Cash Flow | $11.7M | -10.8% |
| Free Cash Flow | $23.4M | +905.4% |
| +19.7% |
| EPS (Basic) | -$1.02 | +22.7% |
| EPS (Diluted) | -$1.02 | +22.7% |